- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
Britannia admitted it hadn’t disclosed certain investigator-led trials. The Panel couldn’t rule on trial disclosure clauses due to missing information, but found…
Complaint alleged pre-licence promotion of eptinezumab and inappropriate “exciting/innovative” wording at a Lundbeck-funded migraine preceptorship. Panel found no evidence of promotion or…
Roche’s HCP website displayed required prescribing information and adverse event reporting statements less prominently on some smartphones (moved into a hamburger menu…
A webinar invitation email appeared to come from an independent organisation and did not mention Thornton & Ross. Sponsorship was only disclosed…
Two Novartis employees ‘liked’ and one commented on a patient advocate’s LinkedIn post about Gleevec/Glivec. The Panel found misleading, unsubstantiated claims and…
A NICE TA694 summary card referenced use with statins but didn’t make the simvastatin >40mg contraindication immediately apparent in the main body.…
Complaint alleged Juvéderm UK site linked users to US Botox promotional pages/social media. Panel found matter in scope but ruled no breach…
Employee alleged a manager suggested “dressing down” to avoid looking like a rep and access hospitals during Covid. PMCPA found insufficient evidence…
A rep supplied Methofill injector training materials to a children’s gastroenterology nurse without immediately stating paediatric Crohn’s use was off-label. Breach of…
A UK press release said Nilemdo “can be combined with other oral treatments” but didn’t make the simvastatin >40mg contraindication immediately apparent.…
PMCPA found sales aids, leavepieces and rep briefing docs implied Nilemdo/Nustendi could be added to any statin dose. Simvastatin >40mg contraindication wasn’t…
Five Observer articles alleged Novo Nordisk used payments, grants and PR to shape the obesity debate and influence NICE/NHS. PMCPA assessed multiple…
GSK’s Trelegy site and ERS leavepiece used broad superiority messaging and visuals that implied statistical significance where it wasn’t shown, plus an…
An ALK-Abelló representative posted about Jext on Facebook with a link to the product website and urged people to share. PMCPA ruled…
Employee alleged Auxilium CRT (a MEGS) was used as disguised promotion to boost Imfinzi during COVID-19 and reflected poor culture. PMCPA Panel…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.